Wang‐Dong Xu
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- Psoriasis: Treatment and Pathogenesis
- T-cell and B-cell Immunology
- IL-33, ST2, and ILC Pathways
- Rheumatology top 2%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
Papers in
- Rheumatology 60
- Systemic Lupus Erythematosus Research 53
- Rheumatoid Arthritis Research and Therapies 10
- Immunology 66
- T-cell and B-cell Immunology 24
- Psoriasis: Treatment and Pathogenesis 12
- Immune Cell Function and Interaction 12
Wang‐Dong Xu
116 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 122
- Immunology 972
- Rheumatology 571
- Dermatology 169
- Cancer Research 243
- Nephrology 93
Countries citing papers authored by Wang‐Dong Xu
This map shows the geographic impact of Wang‐Dong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang‐Dong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang‐Dong Xu more than expected).
Fields of papers citing papers by Wang‐Dong Xu
This network shows the impact of papers produced by Wang‐Dong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang‐Dong Xu. The network helps show where Wang‐Dong Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wang‐Dong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 13 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 15 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 16 | |
| 11 | 2020 | 2 | |
| 12 | 2017 | 5 | |
| 13 | 2016 | 9 | |
| 14 | 2016 | 27 | |
| 15 | 2012 | 2 | |
| 16 | 2012 | 35 | |
| 17 | 2012 | 14 | |
| 18 | 2012 | 64 | |
| 19 | 2012 | 17 | |
| 20 | 2012 | 10 |
About Wang‐Dong Xu
Wang‐Dong Xu is a scholar working on Rheumatology, Immunology, Hematology, Dermatology and Oncology, having authored 117 papers that have together received 2.1k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (53 papers), T-cell and B-cell Immunology (24 papers), Cytokine Signaling Pathways and Interactions (23 papers), Autoimmune and Inflammatory Disorders Research (12 papers), Psoriasis: Treatment and Pathogenesis (12 papers), Immune Cell Function and Interaction (12 papers), Rheumatoid Arthritis Research and Therapies (10 papers) and Dermatology and Skin Diseases (9 papers). The work is most often cited by research in Immunology (972 citations), Rheumatology (571 citations), Dermatology (169 citations), Cancer Research (243 citations) and Nephrology (93 citations). Wang‐Dong Xu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include An‐Fang Huang, Dong‐Qing Ye, Hai‐Feng Pan, Linchong Su, Yi Zhao, Yi Liu, Xiaoyan Liu, Yan Liang, Yuekang Xu and Hui Peng. Their work appears in journals such as Frontiers in Immunology, Scientific Reports, Clinical Rheumatology, Inflammation Research and Autoimmunity Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.